Page last updated: 2024-11-01

ondansetron and Spinal Diseases

ondansetron has been researched along with Spinal Diseases in 1 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Spinal Diseases: Diseases involving the SPINE.

Research Excerpts

ExcerptRelevanceReference
"To compare the effect of ramosetron with that of ondansetron on opioid-based IV patient-controlled analgesia (PCA) related postoperative nausea and vomiting (PONV) in highly susceptible patients after lumbar spine surgery."5.13Effect of ramosetron on patient-controlled analgesia related nausea and vomiting after spine surgery in highly susceptible patients: comparison with ondansetron. ( Choi, YS; Jeon, DH; Kwak, YL; Lee, JY; Shim, JK; Yoon, DH, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, YS1
Shim, JK1
Yoon, DH1
Jeon, DH1
Lee, JY1
Kwak, YL1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Prophylactic Antiemetic Efficacy of Palonosetron Versus Ondansetron for the Prophylaxis of Postoperative Nausea and Vomiting (PONV) in Women Over 60 Years Undergoing Laparoscopic Cholecystectomy[NCT02541019]Phase 480 participants (Actual)Interventional2015-10-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for ondansetron and Spinal Diseases

ArticleYear
Effect of ramosetron on patient-controlled analgesia related nausea and vomiting after spine surgery in highly susceptible patients: comparison with ondansetron.
    Spine, 2008, Aug-01, Volume: 33, Issue:17

    Topics: Adolescent; Adult; Aged; Analgesia, Patient-Controlled; Benzimidazoles; Double-Blind Method; Female;

2008